Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Arista Networks heads into its November 2 earnings date with the stock up 11% over the past month, analysts broadly bullish, and short sellers nowhere near the picture.
The most striking feature of the current setup is how little resistance the stock faces from bears. Short interest runs at just 1.03% of the free float, a level low enough that it barely registers as a positioning story. That figure has edged roughly half a percent lower over the past week, continuing a drift down from a mid-September peak around 14.8 million shares short. Borrow conditions reinforce the picture: the cost to borrow is a negligible 0.51%, and availability is effectively unconstrained, with the lending pool holding vastly more shares than anyone is trying to borrow. The short score of 29.6 ranks in the 82nd percentile for short score rank, which reflects how unremarkable the bear positioning is. Options are similarly calm. The put/call ratio at 0.85 is fractionally below its 20-day average of 0.86, a z-score of minus 0.58, meaning options traders are not reaching for protection. The 52-week range runs from 0.67 to 1.05, and the current reading sits near the middle, closer to complacent than defensive.
The Street is firmly in the bull camp, and recent analyst activity has reinforced that direction. Bernstein initiated coverage with an Outperform rating and a $250 target as recently as September 30. Deutsche Bank also launched coverage at Buy in early September. Those fresh initiations follow a wave of post-earnings target hikes in August, with Barclays lifting to $289, UBS to $259, and Wells Fargo to $255, all after the Q2 print landed. Morgan Stanley raised its target to $220 while maintaining Overweight. The mean price target across the coverage universe is $242.55, roughly 13% above the current price of $215.36. The bulls point to a 2026 revenue growth outlook of around 28%, AI revenue guidance raised to $3.5 billion, 35% year-on-year sales growth and a 47.8% operating margin in the most recent quarter. Bears counter that near-term supply constraints from single-source suppliers create a gap between customer capex commitments and actual shipment timing, and that concentration around Microsoft and Meta, accounting for roughly three-quarters of North American sales, leaves the business exposed to any softening in hyperscaler spending. The valuation is not cheap: trailing PE of 43.5, EV/EBITDA of 33.6, and a price-to-book of 12.2, with the PE up about 3.4 points over the past month as the stock has run.
Ownership is concentrated among insiders and long-only institutions, with no activist presence on the register. Co-founder Andreas Bechtolsheim holds 14.3% of shares, and BlackRock and Vanguard together account for another 13%. Capital Research added 3.8 million shares in the quarter to September 30, and State Street added 1.4 million. Both CEO Jayshree Ullal and President and CTO Kenneth Duda sold stock in late September, but all trades were executed under pre-arranged 10b5-1 plans, which reduces their signal value as a read on management conviction. Ullal sold roughly 62,600 shares at around $211, worth approximately $13 million in aggregate, consistent with a programmatic selling schedule rather than a discretionary view.
Among peers, Ciena was the standout mover this week, up 25% on the week and 13.8% on Tuesday alone, a reminder that the broader networking and optical infrastructure group is catching a bid. Cisco added 10.3% over the week, and Lumentum gained 16.4%. Arista's 6.2% weekly gain is solid but trails several of its correlated names, suggesting the AI networking theme is broadening beyond the obvious leader.
With the next earnings report 26 days away, the conversation ahead is whether Arista can sustain its shipment pace against supply constraints while maintaining the margin profile that has driven the stock's 64% year-to-date gain.
See the live data behind this article on ORTEX.
Open ANET on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
